Methamphetamine and Ovarian Steroid Responsive Cells in the Posteriodorsal Medial Amygdala are Required for Methamphetamine-enhanced Proceptive Behaviors.

Katrina M Williams, Jessica A Mong
Author Information
  1. Katrina M Williams: Program in Molecular Medicine, Department of Pharmacology, University of Maryland, Baltimore, MD, USA.
  2. Jessica A Mong: Department of Pharmacology, Program in Neuroscience, University of Maryland, Baltimore, MD, USA.

Abstract

Methamphetamine (Meth) is a psychomotor stimulant strongly associated with increases in sexual drive and impulse in both men and women. These changes in sexual motivation have a greater impact on women due to their likelihood of facing the greater burden of unplanned pregnancies, as well as increased risk for psychiatric co-morbidities such as depression. We have previously established a rodent model of Meth-induced increases in sexual motivation. Using this model, we have identified the posteriodorsal medial amygdala (MePD) via excitotoxic lesion studies as a necessary nucleus in Meth-facilitated female sexual motivation. While lesion studies give us insight into key nuclei that may be targets of Meth action, such an approach does not give insight into the identity of the specific MePD neurons or neural circuitry involved in Meth-induced increases in proceptive behaviors. Using the DAUN02 inactivation method, a recently established technique for removing behaviorally relevant cell populations, we present evidence that the ovarian steroid/Meth responsive cells in the MePD are necessary for Meth-induced facilitation of proceptive behaviors. These findings form the basis for future work that will allow for the classification of neuronal subtypes involved in the MePD's modulation of proceptive behavior as well as a stronger understanding of the neurocircuitry of female sexual motivation.

References

  1. Brain Res. 1993 Oct 8;624(1-2):253-67 [PMID: 8252398]
  2. Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70 [PMID: 12111114]
  3. Biomed Environ Sci. 2013 Jan;26(1):32-9 [PMID: 23294613]
  4. Brain Res Dev Brain Res. 1996 May 31;93(1-2):191-7 [PMID: 8804706]
  5. Curr Drug Abuse Rev. 2008 Nov;1(3):292-6 [PMID: 19630727]
  6. Public Health Rep. 2006 Mar-Apr;121(2):127-32 [PMID: 16528944]
  7. Behav Neurosci. 2009 Apr;123(2):369-81 [PMID: 19331460]
  8. J Am Assoc Nurse Pract. 2014 Nov;26(11):620-8 [PMID: 24510626]
  9. Brain Res. 1993 Sep 3;621(1):25-34 [PMID: 8221071]
  10. Horm Behav. 2010 Jun;58(1):138-48 [PMID: 20025882]
  11. Brain Res Bull. 1993;32(5):447-51 [PMID: 8221135]
  12. ACS Chem Neurosci. 2016 Oct 19;7(10 ):1364-1373 [PMID: 27501345]
  13. Psychoneuroendocrinology. 2010 Feb;35(2):197-208 [PMID: 19589643]
  14. J Neurosci. 2014 May 28;34(22):7437-46 [PMID: 24872549]
  15. Physiol Behav. 1980 Jun;24(6):1073-80 [PMID: 7413786]
  16. Curr Protoc Neurosci. 2016 Jul 01;76:8.36.1-8.36.17 [PMID: 27367964]
  17. J Neuroendocrinol. 1993 Oct;5(5):557-68 [PMID: 8680425]
  18. Addict Behav. 2004 Jun;29(4):807-10 [PMID: 15135564]
  19. J Subst Abuse Treat. 2002 Mar;22(2):103-8 [PMID: 11932136]
  20. J Drug Alcohol Res. 2016 May;5:null [PMID: 27284493]
  21. Behav Brain Res. 2009 Jun 25;200(2):268-76 [PMID: 19374011]
  22. Addict Disord Their Treat. 2012 Jun 1;11(2):53-63 [PMID: 23559891]
  23. Behav Brain Res. 1998 May;92(2):181-93 [PMID: 9638960]
  24. Neuroscience. 2012 Mar 29;206:100-14 [PMID: 22266344]
  25. Horm Behav. 2015 Jan;67:1-11 [PMID: 25448531]
  26. Cancer Res. 1986 Jun;46(6):2659-64 [PMID: 2421881]
  27. Psychopharmacology (Berl). 2011 May;215(2):353-65 [PMID: 21229349]
  28. Nat Neurosci. 2009 Aug;12(8):1069-73 [PMID: 19620976]
  29. Horm Behav. 2016 Feb;78:52-9 [PMID: 26497407]
  30. J Neurosci. 2015 Jul 29;35(30):10750-61 [PMID: 26224858]
  31. Behav Brain Res. 1984 Mar;11(3):205-12 [PMID: 6326783]
  32. Int J Drug Policy. 2012 Sep;23(5):385-92 [PMID: 22954501]
  33. Horm Behav. 2008 Nov;54(5):709-16 [PMID: 18721808]
  34. Horm Behav. 2006 Jan;49(1):30-7 [PMID: 15955535]
  35. Neuroscience. 2016 Oct 29;335:20-9 [PMID: 27544406]
  36. Women Health. 2004;40(3):35-50 [PMID: 15829444]
  37. Jpn J Physiol. 2005 Dec;55(6):345-53 [PMID: 16409669]
  38. Horm Behav. 1989 Dec;23(4):473-502 [PMID: 2691387]
  39. Horm Behav. 2010 Aug;58(3):519-25 [PMID: 20399784]

Grants

  1. R01 DA030517/NIDA NIH HHS

MeSH Term

Amphetamine-Related Disorders
Amygdala
Animals
Estradiol
Female
Methamphetamine
Motivation
Neurons
Ovary
Progesterone
Rats
Rats, Sprague-Dawley
Sexual Behavior

Chemicals

Methamphetamine
Progesterone
Estradiol

Word Cloud

Created with Highcharts 10.0.0sexualmotivationincreasesMeth-inducedMePDproceptiveMethamphetamineMethwomengreaterwellestablishedmodelUsinglesionstudiesnecessaryfemalegiveinsightinvolvedbehaviorspsychomotorstimulantstronglyassociateddriveimpulsemenchangesimpactduelikelihoodfacingburdenunplannedpregnanciesincreasedriskpsychiatricco-morbiditiesdepressionpreviouslyrodentidentifiedposteriodorsalmedialamygdalaviaexcitotoxicnucleusMeth-facilitateduskeynucleimaytargetsactionapproachidentityspecificneuronsneuralcircuitryDAUN02inactivationmethodrecentlytechniqueremovingbehaviorallyrelevantcellpopulationspresentevidenceovariansteroid/MethresponsivecellsfacilitationfindingsformbasisfutureworkwillallowclassificationneuronalsubtypesMePD'smodulationbehaviorstrongerunderstandingneurocircuitryOvarianSteroidResponsiveCellsPosteriodorsalMedialAmygdalaRequiredMethamphetamine-enhancedProceptiveBehaviors

Similar Articles

Cited By (3)